These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
256 related articles for article (PubMed ID: 15186201)
1. Penile involvement with hand-foot syndrome. Sorscher SM Am J Clin Dermatol; 2004; 5(3):209-10. PubMed ID: 15186201 [TBL] [Abstract][Full Text] [Related]
2. [Plantar-palmar erythrodysesthesia. A new and relatively frequent side effect in antineoplastic treatment]. Risum S; Langer SW Ugeskr Laeger; 2003 Aug; 165(33):3161-2. PubMed ID: 12968412 [TBL] [Abstract][Full Text] [Related]
3. Hand-foot syndrome (hand-foot skin reaction, palmar-plantar erythrodysesthesia): focus on sorafenib and sunitinib. Lipworth AD; Robert C; Zhu AX Oncology; 2009; 77(5):257-71. PubMed ID: 19923864 [TBL] [Abstract][Full Text] [Related]
4. A case of docetaxel-induced erythrodysesthesia. Katoh M; Kadota M; Nishimura Y J Dermatol; 2004 May; 31(5):403-6. PubMed ID: 15187308 [TBL] [Abstract][Full Text] [Related]
5. Increased mast cell density in capecitabine-induced hand-foot syndrome: a new pathologic finding. Latif S; Fraga G; Gadzia J J Drugs Dermatol; 2010 Mar; 9(3):268-70. PubMed ID: 20232590 [TBL] [Abstract][Full Text] [Related]
8. Palmar-plantar erythrodysesthesia (PPE): a literature review with commentary on experience in a cancer centre. Webster-Gandy JD; How C; Harrold K Eur J Oncol Nurs; 2007 Jul; 11(3):238-46. PubMed ID: 17350337 [TBL] [Abstract][Full Text] [Related]
9. Toxic erythema of palms and soles associated with high-dose mercaptopurine chemotherapy. Cox GJ; Robertson DB Arch Dermatol; 1986 Dec; 122(12):1413-4. PubMed ID: 2947543 [TBL] [Abstract][Full Text] [Related]
11. [Dermatologic toxicity to sorafenib]. Velázquez D; de la Cueva P; Zamberk P; Lázaro P Actas Dermosifiliogr; 2009; 100(6):518-20. PubMed ID: 19709563 [No Abstract] [Full Text] [Related]
12. The hand-foot syndrome--a frequent secondary manifestation in antineoplastic chemotherapy. Janusch M; Fischer M; Marsch WCh; Holzhausen HJ; Kegel T; Helmbold P Eur J Dermatol; 2006; 16(5):494-9. PubMed ID: 17101468 [TBL] [Abstract][Full Text] [Related]
13. Fluorouracil and palmar-plantar erythrodysesthesia. Curran CF; Luce JK Ann Intern Med; 1989 Nov; 111(10):858. PubMed ID: 2817635 [No Abstract] [Full Text] [Related]
14. Images in clinical medicine. Palmar-plantar rash with cytarabine therapy. Rosenbeck L; Kiel PJ N Engl J Med; 2011 Jan; 364(3):e5. PubMed ID: 21247311 [No Abstract] [Full Text] [Related]
15. Three cases of chemotherapy-induced acral erythema. Komamura H; Higashiyama M; Hashimoto K; Takeda K; Kimura H; Tani Y; Ogawa H; Yoshikawa K J Dermatol; 1995 Feb; 22(2):116-21. PubMed ID: 7722086 [TBL] [Abstract][Full Text] [Related]
16. Cutaneous toxicities of the multikinase inhibitors sorafenib and sunitinib. McLellan B; Kerr H Dermatol Ther; 2011; 24(4):396-400. PubMed ID: 21910797 [TBL] [Abstract][Full Text] [Related]
17. Capecitabine-induced diffuse palmoplantar keratoderma: is it a sequential event of hand-foot syndrome? Do JE; Kim YC Clin Exp Dermatol; 2007 Sep; 32(5):519-21. PubMed ID: 17509060 [TBL] [Abstract][Full Text] [Related]
18. [A man with blisters on hand and feet]. Gelderblom AJ; van der Rhee JI; Ouwerkerk J Ned Tijdschr Geneeskd; 2011; 155(45):A3994. PubMed ID: 22085574 [TBL] [Abstract][Full Text] [Related]